>…product based biotech firms had M&A revenue multiples of 10.4x ...using only the $75M in revenue figure, it would mean that we'd be looking at $750-$800M<
Please see Msg# 7659. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”